New Option for HER2+ MBC Patients

Options
Bestbird
Bestbird Member Posts: 2,818
edited June 2019 in Stage IV/Metastatic Breast Cancer ONLY

Currently Herceptin (Trastuzumab) is administered intravenously. The good news is that in Feb. 2019 a subcutaneous injection called "Herceptin Hylecta" consisting of Herceptin plus a substance called hyaluronidase-oysk was FDA-approved in combination with Taxol as first line treatment for HER2+ MBC patients, or as a stand-alone therapy for HER2+ MBC patients who have received one or more lines of chemotherapy for their disease. From: https://www.gene.com/patients/medicines/herceptin-hylecta

The above information has been incorporated into my book, "The Insider's Guide to Metastatic Breast Cancer" which is now offered in paperback and eBook format on Amazon at https://www.amazon.com/Insiders-Guide-Metastatic-Breast-Cancer/dp/179586060 X/ref=sr_1_fkmrnull_1?crid=2EL3W64I1UXA0&keywords=the+insider%27s+guide+to+ metastatic+breast+cancer&qid=1550509998&s=gateway&sprefix=insiders+guide+to +me%2Caps%2C684&sr=8-1-fkmrnull

Those wishing to receive a complimentary .pdf version are welcome to email me at bestbird@hotmail.com

With good wishes.

· Share on FacebookShare on Twitter

Comments

  • Anonymous
    Anonymous Member Posts: 1,376
    edited June 2019

    I was waiting for this to be approved in the USA! I knew about it before my infusion center nurses did, thanks to BCO.

    Any stage IV ladies getting the Herceptin injection in the USA yet

    · Share on FacebookShare on Twitter

Categories